InsideArbitrage Potential Deal Alert: Walmart In Talks to Buy TV Maker Vizio (VZIO)
According to WSJ, Walmart (WMT) is in talks to buy smart television-manufacturer Vizio (VZIO) for more than $2 billion. Vizio Investor Relations
Read MoreAccording to WSJ, Walmart (WMT) is in talks to buy smart television-manufacturer Vizio (VZIO) for more than $2 billion. Vizio Investor Relations
Read MoreTripAdvisor (TRIP) said its board of directors formed a special committee to evaluate any proposals that may be brought forward for a potential transaction. The
Read MoreSoho House & Co (SHCO) announced that in the fall of 2023, the Board formed an independent Special Committee of the Board to evaluate strategic
Read MoreAccording to Reuters, U.S. oil and gas producer Devon Energy (DVN) has approached Enerplus (ERF) a peer with a market value of C$4 billion ($3
Read MoreAccording to Reuters, Vision One Management Partners, a fund co-founded by former Canadian Prime Minister Stephen Harper and former Carl Icahn protege Courtney Mather has built
Read MoreOverseas Shipholding Group (OSG), a leading provider of liquid bulk transportation services confirmed that OSG’s Board of Directors received an unsolicited non-binding indication of interest
Read MoreGamida Cell (GMDA) announced it is actively pursuing strategic alternatives to maximize value for all stakeholders, focusing on an asset sale, merger, or other strategic
Read MoreAccording to Bloomberg, Dyne Therapeutics (DYN) a developer of drugs to treat muscle diseases, is considering options after receiving takeover interest from larger pharmaceutical companies.
Read MoreAccording to Bloomberg, Tellurian (TELL) has engaged Lazard to evaluate a potential sale. Tellurian Investor Relations Update(s): March 18, 2024: Tellurian (TELL) said it was
Read MoreAccording to Bloomberg, PagerDuty (PD), a provider of services to predict and prevent software calamities, is considering options amid takeover interest from private equity firms.
Read MoreTDCX (TDCX) announced that it has received a preliminary non-binding proposal letter from Founder, Executive Chairman, Director, CEO Laurent Junique to acquire all of the
Read MoreAccording to the 13D filing, Reneo Pharmaceuticals (RPHM) received a non-binding takeover proposal from Concentra Biosciences for $1.80 per share in cash, plus a contingent
Read More